Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma
Munir R. Tanas(Veterans Health Administration), Brian P. Rubin(Cleveland Clinic), Maria Dêbiec‐Rychter(Center for Human Genetics), Philip J. Hanwright(Cleveland Clinic), Marketa Zvelebil(Institute of Cancer Research), Mark A. Rubin(University of Bern), Mark Gerstein(Yale University), Robert B. West(Stanford University), Andrea Sboner(Cornell University), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Rachael Natrajan(Institute of Cancer Research), Alan Ashworth(University of California, San Francisco), Costas Mitsopoulos(Institute of Cancer Research), Jessica Hespelt(Cleveland Clinic), Benjamin Hoch(University of Washington), Jorge S. Reis‐Filho(AstraZeneca (France)), André M. Oliveira(Mayo Clinic in Arizona), Michele R. Erickson‐Johnson(Mayo Clinic), Raf Sciot(KU Leuven), Christopher J. Lord(Institute of Cancer Research), Kerry Fenwick(Institute of Cancer Research), John J. Flanagan(Advanced Cell Diagnostics (United States)), Yuling Luo(Guangdong Pharmaceutical University), Sharon W. Weiss(Tel Aviv University)
Cited by 401
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
RNAscope
|Journal of Molecular Diagnostics|2011|2.7k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
|Nature Biotechnology|2006|2.2k
Comparing protein abundance and mRNA expression levels on a genomic scale.
|Genome Biology|2003|1.7k